Common-Size Income Statement
Paying user area
Try for free
Thermo Fisher Scientific Inc. pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Balance Sheet: Assets
- Common-Size Balance Sheet: Assets
- Analysis of Profitability Ratios
- Net Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Current Ratio since 2005
- Price to Operating Profit (P/OP) since 2005
- Price to Book Value (P/BV) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Thermo Fisher Scientific Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The analysis of the annual financial ratios reveals notable shifts in revenue composition and profitability margins over the five-year period.
- Revenue Composition
- There is a clear decline in the proportion of product revenues relative to total revenues, decreasing from 78.55% in 2020 to 58.38% in 2024. Conversely, service revenues have increased significantly, rising from 21.45% to 41.62% over the same timeframe. This trend suggests a strategic shift towards service offerings or a change in market demand favoring services.
- Costs and Gross Profit
- While cost of product revenues as a percentage of total revenues has decreased from -35.41% to -29.21%, cost of service revenues has increased markedly from -14.92% to -29.51%. As a result, overall cost of revenues rose from -50.33% in 2020 to a peak of -60.1% in 2023 before slightly retreating to -58.72% in 2024. This escalation in costs, particularly of services, has pressured gross profit margins, which declined from 49.67% to 41.28% over the period.
- Operating Expenses
- Selling, general, and administrative expenses have remained relatively stable as a percentage of revenues, fluctuating narrowly around 20%. Research and development expenses showed a modest downward trend from -3.67% to approximately -3.2%. Restructuring and other costs, though small in magnitude, peaked at -1.07% in 2023 and then decreased to -0.89% in 2024.
- Operating Income and Profitability
- Operating income experienced a decrease from 24.19% in 2020 to 17.11% in 2024, with a low point of 16% in 2023. This contraction aligns with the pressures seen in gross profit margins and increased costs in service revenues, indicating operational challenges or investments impacting profitability.
- Interest and Other Income/Expenses
- Interest income increased substantially from 0.2% to 2.51%, while interest expense also rose, more than doubling from -1.72% to -3.24%. Other income (expense) remained minor and mostly negative but turned slightly positive by 2024.
- Income Before Taxes and Net Income
- Income before income taxes followed the operating income trend, declining from 22.44% to 16.41% with a decrease across the period. The provision for income taxes was reduced significantly, from -2.64% down to -1.53%, which helped mitigate some of the income decline. Net income attributable to the company declined from 19.79% in 2020 to 14.77% in 2024, reflecting the cumulative effect of cost pressures and reduced operational margins.
- Noncontrolling Interests
- Amounts attributed to noncontrolling interests have been negligible throughout the period, indicating minimal impact on overall profitability.
Overall, the data indicate a strategic and operational transformation marked by a revenue mix transition favoring services, increased cost burdens associated with this shift, and a consequent reduction in profitability margins. The company appears to be investing in or adapting to a changing market environment, but this has remained a challenge in terms of maintaining previous levels of net and operating incomes.